ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Centivax
Centivax is a biotechnology company developing vaccines and therapeutics against mutation-diverse pathogens using computational bioengineering. They are focused on creating broad-spectrum vaccines and neutralizing antibodies for rapidly evolving viruses such as influenza, SARS-CoV-2, and HIV, currently conducting a Phase 1 clinical study for a universal influenza vaccine.
Headquarters
South San Francisco, California, United States
Company Size
11-50 employees
Centivax is a biotechnology company focused on developing next‑generation vaccines and immunotherapies using platform technologies to elicit robust, durable immune responses. The company concentrates on antigen design, delivery systems and adjuvant strategies to improve breadth and longevity of protection against infectious diseases and cancer. Centivax advances early‑stage research toward clinical development and collaborates with academic and industry partners to translate immunology discoveries into practical vaccines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Centivax.
41% above the average for this role
Scientific Leader, Herpesvirus Research
Gilead Sciences
Postdoctoral Research Associate
PeopleAdmin
Postdoctoral Fellow — Viral Transmission & Vaccine Science
Washington University in St. Louis
Scientist, Virology
GSK plc
Associate Research Scientist
Columbia University
2027 Spring Co-op Virology NA - Global Antigen Design
Sanofi